The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients. / Bremholm, Lasse; Hornum, Mads; Andersen, Ulrik B; Hartmann, Bolette; Holst, Jens Juul; Jeppesen, Palle Bekker.

I: Regulatory Peptides, Bind 168, Nr. 1-3, 2011, s. 32-8.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Bremholm, L, Hornum, M, Andersen, UB, Hartmann, B, Holst, JJ & Jeppesen, PB 2011, 'The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients', Regulatory Peptides, bind 168, nr. 1-3, s. 32-8. https://doi.org/10.1016/j.regpep.2011.03.003

APA

Bremholm, L., Hornum, M., Andersen, U. B., Hartmann, B., Holst, J. J., & Jeppesen, P. B. (2011). The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients. Regulatory Peptides, 168(1-3), 32-8. https://doi.org/10.1016/j.regpep.2011.03.003

Vancouver

Bremholm L, Hornum M, Andersen UB, Hartmann B, Holst JJ, Jeppesen PB. The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients. Regulatory Peptides. 2011;168(1-3):32-8. https://doi.org/10.1016/j.regpep.2011.03.003

Author

Bremholm, Lasse ; Hornum, Mads ; Andersen, Ulrik B ; Hartmann, Bolette ; Holst, Jens Juul ; Jeppesen, Palle Bekker. / The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients. I: Regulatory Peptides. 2011 ; Bind 168, Nr. 1-3. s. 32-8.

Bibtex

@article{96299860bdc04283a716e344fabe5cdc,
title = "The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients",
abstract = "Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.",
keywords = "Adult, Aged, Blood Pressure, Cardiac Output, Female, Glucagon-Like Peptide 2, Heart Rate, Humans, Male, Mesenteric Arteries, Middle Aged, Regional Blood Flow, Short Bowel Syndrome, Young Adult",
author = "Lasse Bremholm and Mads Hornum and Andersen, {Ulrik B} and Bolette Hartmann and Holst, {Jens Juul} and Jeppesen, {Palle Bekker}",
note = "Copyright {\textcopyright} 2011 Elsevier B.V. All rights reserved.",
year = "2011",
doi = "10.1016/j.regpep.2011.03.003",
language = "English",
volume = "168",
pages = "32--8",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "1-3",

}

RIS

TY - JOUR

T1 - The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

AU - Bremholm, Lasse

AU - Hornum, Mads

AU - Andersen, Ulrik B

AU - Hartmann, Bolette

AU - Holst, Jens Juul

AU - Jeppesen, Palle Bekker

N1 - Copyright © 2011 Elsevier B.V. All rights reserved.

PY - 2011

Y1 - 2011

N2 - Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.

AB - Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.

KW - Adult

KW - Aged

KW - Blood Pressure

KW - Cardiac Output

KW - Female

KW - Glucagon-Like Peptide 2

KW - Heart Rate

KW - Humans

KW - Male

KW - Mesenteric Arteries

KW - Middle Aged

KW - Regional Blood Flow

KW - Short Bowel Syndrome

KW - Young Adult

U2 - 10.1016/j.regpep.2011.03.003

DO - 10.1016/j.regpep.2011.03.003

M3 - Journal article

C2 - 21421014

VL - 168

SP - 32

EP - 38

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 1-3

ER -

ID: 34043197